Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz
August 30, 2024
Mizuho news from around the globe
Mizuho Global News